Cepheid
Nupur V. is a Scientist I in Enzyme Development at Cepheid with expertise in COVID-19 research, contributing to pro bono initiatives as State Lead and Scientific Advisor with the COVID-19 National Science Volunteer Database and Crowdfight. Previous roles include Scientist at Omic, Postdoctoral Scholar at the University of California, San Francisco, and Doctoral Researcher at the University of Cambridge, where Nupur led significant projects in drug discovery for Alzheimer's disease and tuberculosis. Education includes a Ph.D. in Drug Discovery, Structural Biology, and Biochemistry from the University of Cambridge and a Master's in Biotechnology from Amity Institute of Biotechnology. Nupur has received recognition as an Outstanding Young Investigator from the Alzheimer's Drug Discovery Foundation and has a strong history of research collaboration and public engagement in science.
This person is not in any teams
This person is not in any offices
Cepheid
10 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.